Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
奥洛达特罗(一种新型长效β2受体激动剂)每日一次治疗哮喘患者的剂量探索性评估:一项平行组研究和一项交叉研究的结果
期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-015-0249-8
O'Byrne, Paul M; D'Urzo, Tony; Beck, Ekkehard; Fležar, Matjaž; Gahlemann, Martina; Hart, Lorna; Blahova, Zuzana; Toorawa, Robert; Beeh, Kai-Michael